Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
about
Enabling large-scale design, synthesis and validation of small molecule protein-protein antagonistsTherapeutic considerations for Mdm2: not just a one trick ponytrans-rac-[1-Oxo-2-phenethyl-3-(2-thien-yl)-1,2,3,4-tetra-hydro-isoquinolin-4-yl]methyl 4-methyl-benzene-sulfonateMethyl trans-(±)-1-oxo-2-phenethyl-3-(thio-phen-2-yl)-1,2,3,4-tetra-hydro-isoquinoline-4-carboxyl-ateNovel targeted therapeutics: inhibitors of MDM2, ALK and PARP.Fragment-based library generation for the discovery of a peptidomimetic p53-Mdm4 inhibitorChemistry and biology of multicomponent reactions.The MDM2-p53 pathway revisitedTargeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?The p53-MDM2/MDMX axis - A chemotype perspective.Patented inhibitors of p53-Mdm2 interaction (2006 - 2008).NMR-based screening of membrane protein ligands.Inhibitors of MDM2 and MDMX: a structural perspective.Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.Prospective virtual screening for novel p53-MDM2 inhibitors using ultrafast shape recognition.Radiosensitization of wildtype p53 cancer cells by the MDM2-inhibitor PXN727 is associated with altered heat shock protein 70 (Hsp70) levels.Understanding small-molecule binding to MDM2: insights into structural effects of isoindolinone inhibitors from NMR spectroscopy.A speedy route to sterically encumbered, benzene-fused derivatives of privileged, naturally occurring hexahydropyrrolo[1,2-b]isoquinoline.Unveiling the "Three-Finger Pharmacophore" Required for p53-MDM2 Inhibition by Saturation-Transfer Difference (STD) NMR Initial Growth-Rates Approach.Stereoselective Synthesis of Quaternary Pyrrolidine-2,3-diones and β-Amino Acids.
P2860
Q28481449-AA762B6A-207A-4BA6-935A-AAE39829745EQ30380490-2884641E-181E-4F49-ACEA-EAC101C615EBQ34223458-AAEABD94-7B5F-4579-BD0A-754592AA07C7Q34265336-F8A30A36-A718-431E-9E75-E32938415D6FQ35011473-79A7EC53-DCFD-48F4-BBCF-BBA908C8DEC2Q35199094-5798A6AF-8984-4E77-BE8B-E697EF503486Q37017587-EFD769C9-822E-4B78-A5B1-1D735E1BEC29Q37039474-DA550BFA-B716-4F09-BCFD-C6153E6F28DEQ37068706-8239143E-5B06-489F-BF08-5E3C90E8443DQ37503463-C3FFE8A8-E994-42FD-B8CC-2C460EBBE618Q37680961-BF8857E9-AE52-4943-A452-03D2E060059AQ37717767-F47F16F9-B065-41C3-B518-E9CD7BF6D09FQ37855826-78BFEEA6-DDD2-49B5-8998-C52377E5E6FBQ38865504-3E5C35CC-4B51-444D-A4F5-B3F24A9EA72BQ39022371-1C297FE9-119A-4042-9979-080C62E71B49Q39288532-0220671B-3261-4DA6-9E3D-58DA70326EF7Q39606430-AEDE7A80-A023-42A6-9E18-ABF6AE00DD51Q41147670-50931A55-8773-43BB-B6E5-4BD44BC1ABF1Q53172454-F5B17576-88BE-4429-AF39-37585BC2158EQ53272138-AD38A407-B6F1-4E55-8F42-D6026A59620A
P2860
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
@en
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
@nl
type
label
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
@en
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
@nl
prefLabel
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
@en
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
@nl
P2093
P356
P1433
P1476
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.
@en
P2093
Anna Czarna
Cédric Kalinski
Günther Ross
Jolanta Ciombor
Lutz Weber
Marcin Krajewski
Natalia Skobeleva
Tad A Holak
Ulli Rothweiler
Vladimir Khazak
P2860
P304
P356
10.1002/CMDC.200800025
P577
2008-07-01T00:00:00Z